HEPHAISTOS-Pharma
Developer of an immunotherapy platform designed to produce the next generation of oncology treatments. The company's platform provides active and non-specific immuno-stimulants to potentiate commercia...
Valuation
$0
Share Price
N/A
Total Raised
$11.3M
Last Round
N/A